Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: Belgium Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20071
20111
20132
20154
20161
20171
20191
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Active, not recruiting2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Eli Lilly and Company2
Novartis Pharmaceuticals2
AbbVie1
Bristol-Myers Squibb1
GlaxoSmithKline1
Hoffmann-La Roche1
Jules Bordet Institute1
Pfizer1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms16
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Glioblastoma4
Melanoma4
Central Nervous System Neoplasms3
Glioma3
Gliosarcoma3
Astrocytoma2
Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.